Scott David Priebe

Array ( [id] => 3924917 [patent_doc_number] => 05876988 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Selection marker gene free recombinant strains: method for obtaining them and the use of these strains' [patent_app_type] => 1 [patent_app_number] => 8/880557 [patent_app_country] => US [patent_app_date] => 1997-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 66 [patent_no_of_words] => 24693 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876988.pdf [firstpage_image] =>[orig_patent_app_number] => 880557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353674 [patent_doc_number] => 06200799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Somatic gene therapy to suppress secondary cataract formation following eye surgery' [patent_app_type] => 1 [patent_app_number] => 8/867902 [patent_app_country] => US [patent_app_date] => 1997-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 7697 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200799.pdf [firstpage_image] =>[orig_patent_app_number] => 867902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781532 [patent_doc_number] => 05821119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Shuttle vectors for Escherichia coli and cyanobateria' [patent_app_type] => 1 [patent_app_number] => 8/855483 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7189 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821119.pdf [firstpage_image] =>[orig_patent_app_number] => 855483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221249 [patent_doc_number] => 06010878 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Interleukin-1 .beta. converting enzyme like apoptotic protease-6' [patent_app_type] => 1 [patent_app_number] => 8/852936 [patent_app_country] => US [patent_app_date] => 1997-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010878.pdf [firstpage_image] =>[orig_patent_app_number] => 852936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4212648 [patent_doc_number] => 06110672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof' [patent_app_type] => 1 [patent_app_number] => 8/836325 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 14 [patent_no_of_words] => 51359 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110672.pdf [firstpage_image] =>[orig_patent_app_number] => 836325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921764 [patent_doc_number] => 20010029249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'ADENOVIRUS COMPRISING A GENE CODING FOR GLUTATHIONE PEROXIDASE' [patent_app_type] => new [patent_app_number] => 08/776786 [patent_app_country] => US [patent_app_date] => 1997-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4283 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029249.pdf [firstpage_image] =>[orig_patent_app_number] => 08776786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1585124 [patent_doc_number] => 06358732 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'DNA for expression under control of a cell cycle-dependent promoter' [patent_app_type] => B1 [patent_app_number] => 08/793110 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6254 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358732.pdf [firstpage_image] =>[orig_patent_app_number] => 08793110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328232 [patent_doc_number] => 06312946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Viable contaminant particle free adenoviruses, their prepartion and use' [patent_app_type] => 1 [patent_app_number] => 8/817575 [patent_app_country] => US [patent_app_date] => 1997-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 14215 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312946.pdf [firstpage_image] =>[orig_patent_app_number] => 817575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288349 [patent_doc_number] => 06235497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Recombinant expression of the rat vesicular acetylcholine transporter' [patent_app_type] => 1 [patent_app_number] => 8/793044 [patent_app_country] => US [patent_app_date] => 1997-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3805 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235497.pdf [firstpage_image] =>[orig_patent_app_number] => 793044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352861 [patent_doc_number] => 06218185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Piggybac transposon-based genetic transformation system for insects' [patent_app_type] => 1 [patent_app_number] => 8/844274 [patent_app_country] => US [patent_app_date] => 1997-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 64 [patent_no_of_words] => 11003 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218185.pdf [firstpage_image] =>[orig_patent_app_number] => 844274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4118406 [patent_doc_number] => 06071892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Tyrosyl tRNA synthetase polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/844054 [patent_app_country] => US [patent_app_date] => 1997-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12533 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071892.pdf [firstpage_image] =>[orig_patent_app_number] => 844054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963423 [patent_doc_number] => 05885777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Cloning, expression and characterization of a novel form of phosphatidylinositol-3-kinase' [patent_app_type] => 1 [patent_app_number] => 8/817090 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5054 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885777.pdf [firstpage_image] =>[orig_patent_app_number] => 817090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770327 [patent_doc_number] => 05807681 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Human retinoblastoma-related (pRb2/p130) genomic DNA and methods for detecting mutations therein' [patent_app_type] => 1 [patent_app_number] => 8/832883 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 16179 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807681.pdf [firstpage_image] =>[orig_patent_app_number] => 832883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4325012 [patent_doc_number] => 06319669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Modified green fluorescent proteins' [patent_app_type] => 1 [patent_app_number] => 8/727452 [patent_app_country] => US [patent_app_date] => 1997-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 7454 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319669.pdf [firstpage_image] =>[orig_patent_app_number] => 727452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062829 [patent_doc_number] => 06008022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Human cytokine polypeptide' [patent_app_type] => 1 [patent_app_number] => 8/820970 [patent_app_country] => US [patent_app_date] => 1997-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20163 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008022.pdf [firstpage_image] =>[orig_patent_app_number] => 820970 [rel_patent_id] =>[rel_patent_doc_number] =>)